Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah J Wexler

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
The New England Journal of Medicine|June 8, 2019
D2d - No Defense against DiabetesDeborah J Wexler
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Inpatient diabetes management in general medical and surgical settings: evidence and updateDeborah J Wexler
JAMA|September 20, 2019
Sulfonylureas and Cardiovascular Safety: The Final Verdict?Deborah J Wexler
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 5, 2006
Low risk of depression in diabetes? Would that it were soDeborah J Wexler
Current Diabetes Reviews|January 29, 2008
Inpatient diabetes management in non-ICU settings: evidence and strategiesDeborah J Wexler, Enrico Cagliero
Evidence-Based Medicine|November 23, 2012
Lower blood pressure associated with higher mortality in retrospective study of patients with newly diagnosed type 2 diabetesRichard W Grant, Deborah J Wexler
Expert Review of Cardiovascular Therapy|March 13, 2010
Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testingRichard W Grant, Deborah J Wexler
Current Diabetes Reports|January 31, 2014
Effectiveness of diabetes interventions in the patient-centered medical homeSarah A Ackroyd, Deborah J Wexler
Evidence-Based Medicine|September 24, 2010
Intensive dietary advice significantly improves HbA(1c) in patients with type II diabetes who remain hyperglycaemic despite optimised drug treatmentDeborah J Wexler, Richard W Grant
Diabetes Management (London, England)|July 2, 2013
Personalized medicine in Type 2 diabetes: what does the future hold?Richard W Grant, Deborah J Wexler
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
The New England Journal of Medicine|June 8, 2019
D2d - No Defense against DiabetesDeborah J Wexler
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Inpatient diabetes management in general medical and surgical settings: evidence and updateDeborah J Wexler
JAMA|September 20, 2019
Sulfonylureas and Cardiovascular Safety: The Final Verdict?Deborah J Wexler
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 5, 2006
Low risk of depression in diabetes? Would that it were soDeborah J Wexler
Current Diabetes Reviews|January 29, 2008
Inpatient diabetes management in non-ICU settings: evidence and strategiesDeborah J Wexler, Enrico Cagliero
Evidence-Based Medicine|November 23, 2012
Lower blood pressure associated with higher mortality in retrospective study of patients with newly diagnosed type 2 diabetesRichard W Grant, Deborah J Wexler
Expert Review of Cardiovascular Therapy|March 13, 2010
Loss-of-function CYP2C9 variants: finding the correct clinical role for Type 2 diabetes pharmacogenetic testingRichard W Grant, Deborah J Wexler
Current Diabetes Reports|January 31, 2014
Effectiveness of diabetes interventions in the patient-centered medical homeSarah A Ackroyd, Deborah J Wexler
Evidence-Based Medicine|September 24, 2010
Intensive dietary advice significantly improves HbA(1c) in patients with type II diabetes who remain hyperglycaemic despite optimised drug treatmentDeborah J Wexler, Richard W Grant
Diabetes Management (London, England)|July 2, 2013
Personalized medicine in Type 2 diabetes: what does the future hold?Richard W Grant, Deborah J Wexler
Pageof 18